AAAAAA
Results: 1-25/46
Authors:
Bernardo, J
Eliseu, T
Miller, R
Andrade, R
Galiano, A
Ferreira, M
Xavier, R
Silva, J
Citation: J. Bernardo et al., Drug-resistance profile of Mycobacterium tuberculosis complex strains in 151 Portuguese inmate patients, with HIV co-infection, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 3-7
Authors:
Clotet, B
Paredes, R
Martinez-Picado, J
Tural, C
Ruiz, L
Citation: B. Clotet et al., It is necessary to start with protease inhibitors?, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 9-17
Authors:
Sarmento-Castro, R
Horta, A
Vasconcelos, O
Vasconcelos, A
Coelho, H
Veloso, S
Rocha-Marques, A
Barros, AS
Braga, J
Viegas, E
Gonzalez, J
Forte, O
Recalde, C
Citation: R. Sarmento-castro et al., DOT in patients with tuberculosis and HIV infection, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 19-21
Authors:
Araujo, F
Miranda, M
Koch, MC
Henriques, I
Lacerda, P
Meireles, E
Monteiro, E
Cunha-Ribeiro, LM
Citation: F. Araujo et al., Haemophilia and HIV-1 and/or HIV-2 infection. The role of polymorphisms inchemokines and chemokines receptors genes, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 25-28
Authors:
Weiel, J
Croom, D
Furfine, E
Spaltenstein, A
Lenhard, J
Citation: J. Weiel et al., Influence of diet and genetics on metabolic abnormalities in mice treated with HIV protease inhibitors, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 31-34
Authors:
Kindelan, JM
Vidal, E
Madueno, J
Gimenez-Domenech, R
Viciana, P
Causse, M
Baron, B
Marquez, M
Gomez-Mateos, J
Perez-Cortes, S
Pasquau, J
Vergara, A
Rodriguez-Banos, J
Perez-Guzman, E
Merino, D
Citation: Jm. Kindelan et al., Primary genotypic resistance to nucleoside analogues in naive HIV-infectedpatients in Andalusia (Spain), SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 37-41
Authors:
Perez-Gracia, MT
Lopez-Barba, J
Galan-Sanchez, F
Garcia-Valdivia, MS
Rodriguez-Iglesian, MA
Citation: Mt. Perez-gracia et al., Mutations detection in HIV-1 protease gene through a sequencing method using digoxigenin labeled primers, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 43-47
Authors:
Ruiz, L
Negredo, E
Ruiz, L
Citation: L. Ruiz et al., Benefit of switching the Protease Inhibitor (PI) by nevirapine in PI - experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL). Interim analysis at 6 months of follw-up, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 49-54
Authors:
Vigano, MG
Fumagalli, L
Soldini, L
Tradati, P
Lazzarin, A
Citation: Mg. Vigano et al., Interleukin-12 plasma concentrations in HIV-positive patients affected by neoplasms: preliminary data, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 57-60
Authors:
Pynka, M
Bander, D
Wnuk, A
Ostanek, L
Fiedorowicz-Fabrycy, I
Boron-Kaczmarska, A
Citation: M. Pynka et al., Panniculitis in a HIV(+) pregnant woman, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 63-66
Authors:
Chaillou, S
Durant, J
Clevenbergh, P
Rahelinirina, V
Garraffo, R
Schapiro, JM
Dellamonica, P
Citation: S. Chaillou et al., Long term effectiveness of Saquinavir and Ritonavir low dosage (baby-dose)in HIV patients failing combination therapy: correlation of response to treatment with genotype mutations and pharmacological data, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 69-72
Authors:
Chrysos, G
Mangafas, N
Tsekes, G
Paraskeva, D
Kamaratos, A
Antonopoulos, S
Lazanas, MK
Citation: G. Chrysos et al., Changes in lipid profile of HIV infected patients treated with protease inhibitors, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 73-76
Authors:
Delassus, JL
Maisonneuve, L
Malbec, D
Boudon, P
Lepennec, MP
Citation: Jl. Delassus et al., Comparison of AZT+3TC+Nevirapine and D4T+DDI+Nevirapine in naive patients during 52 weeks, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 77-80
Authors:
Filippini, P
Coppola, N
Scolastico, C
Liorre, G
Nocera, R
Sagnelli, E
Piccinino, F
Citation: P. Filippini et al., HCV infection and anti-retroviral treatment, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 81-85
Authors:
Gianotti, N
Moretti, F
Tambussi, G
Nozza, S
Ciuffreda, D
Lazzarin, A
Racca, S
Boeri, E
Crucianelli, R
Ferrari, M
Moroni, M
Angarano, G
Sinicco, A
Citation: N. Gianotti et al., SMART - study on mutations and antiretroviral therapy: preliminary results, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 87-91
Authors:
Husstedt, IW
Evers, S
Lang, S
Bockenholt, S
Heese, C
Reichelt, D
Citation: Iw. Husstedt et al., Event related potentials and HIV-associated encephalopathy during HAART incomparison to ART, antiretroviral monotherapy and antiretroviral naive patients, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 93-95
Authors:
Kazatchkine, MD
Citation: Md. Kazatchkine, Didanosine dosed once a day is equivalent to bid dosing in patients on double or triple combination antiretroviral therapy, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 97-101
Authors:
Maggiolo, F
Migliorino, M
Maserati, R
Rizzi, L
Pravettoni, G
Suter, E
Citation: F. Maggiolo et al., Once-a-day HAART for HIV infection, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 103-106
Authors:
Raise, E
Rosini, G
Pasquinucci, S
Bechi, M
Scarpa, M
Ortolani, C
De Toffoli, A
Citation: E. Raise et al., Efficacy and safety of efavirenz in combination with NRTI in HIV positive patients, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 107-110
Authors:
Resta, F
Buccoliero, G
Cristiano, L
Lonero, G
Federico, M
Angelini, P
Caliendo, C
Chimienti, A
Citation: F. Resta et al., Switch therapy to nevirapine for protease inhibitor in HIV-1 positive patients with undetectable plasma viral load, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 111-113
Authors:
Rocher, A
Vargas, A
Perez, MD
Sanchez, A
Nunez, E
Citation: A. Rocher et al., VIH treatment: complexity versus compliance, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 115-118
Authors:
Russell, D
Bal, J
Anderson, J
Moore, R
Russell, J
Citation: D. Russell et al., The efficacy of Nevirapine at low versus high viral loads, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 119-123
Authors:
Tsekes, G
Chrysos, G
Douskas, G
Paraskeva, D
Mangafas, N
Papanikolaou, M
Giannakopoulos, D
Georgiou, E
Lazanas, MC
Citation: G. Tsekes et al., Body composition by DEXA in PIs-naive HIV-infected patients treated with two nucleoside analogues, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 125-129
Authors:
Maltez, F
Machado, J
Garragorri, M
Lourenco, S
Morgado, A
Proenca, R
Citation: F. Maltez et al., Cutaneous and visceral Leishmaniasis in HIV positive and HIV negative patients, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 133-135
Authors:
Mendes-Correa, MC
Duarte, MI
Patzina, R
Citation: Mc. Mendes-correa et al., Histological and clinical characteristics of hepatitis C in HIV infected patients, in Brazil, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 137-139